SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Valeant Pharmaceuticals International Buys-Out Rights to All Current and Future Income and Milestone Obligations From Former Dow Pharmaceutical Sciences (JOBS) Stockholders for $115M